Response to MEK inhibitor in small cell neuroendocrine carcinoma of the cervix with a KRAS mutation

by Yasmin A. Lyons, Michael Frumovitz, Pamela T. Soliman
Published 2014-12-01

Immune cell profiling in cancer: molecular approaches to cell-specific identification

by Yasmin A. Lyons, Sherry Y. Wu, Willem W. Overwijk, Keith A. Baggerly, Anil K. Sood
Published 2017-08-01

A rectovaginal septum mass in a BRCA1 positive patient years after risk reducing surgery: A case report

by Logan Blankenship, Yasmin A. Lyons, Haisar Dao Campi, Philip T. Valente, Laura Barnes, Edward R. Kost
Published 2021-05-01

Combined VEGFR and MAPK pathway inhibition in angiosarcoma

by Michael J. Wagner, Yasmin A. Lyons, Jean H. Siedel, Robert Dood, Archana S. Nagaraja, Monika Haemmerle, Lingegowda S. Mangala, Pritha Chanana, Alexander J. Lazar, Wei-Lien Wang, Vinod Ravi, Eric C. Holland, Anil K. Sood
Published 2021-04-01

Role of CTGF in Sensitivity to Hyperthermia in Ovarian and Uterine Cancers

by Hiroto Hatakeyama, Sherry Y. Wu, Yasmin A. Lyons, Sunila Pradeep, Wanqin Wang, Qian Huang, Karem A. Court, Tao Liu, Song Nie, Cristian Rodriguez-Aguayo, Fangrong Shen, Yan Huang, Takeshi Hisamatsu, Takashi Mitamura, Nicholas Jennings, Jeajun Shim, Piotr L. Dorniak, Lingegowda S. Mangala, Marco Petrillo, Vladislav A. Petyuk, Athena A. Schepmoes, Anil K. Shukla, Madeline Torres-Lugo, Ju-Seog Lee, Karin D. Rodland, Anna Fagotti, Gabriel Lopez-Berestein, Chun Li, Anil K. Sood
Published 2016-11-01